Max Healthcare Institute Ltd's Q3FY25 Quarter Results
Max Healthcare Institute Ltd's revenue increased 37.7% YoY
- 2d ago
Result Summary
- Max Healthcare Institute Ltd reported a 8.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 37.7%.
- Its expenses for the quarter were up by 10.5% QoQ and 48.7% YoY.
- The net profit decreased 15.3% QoQ and decreased 17.5% YoY.
- The earnings per share (EPS) of Max Healthcare Institute Ltd stood at 2.4 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 1901.61 | 1748.30 | 1380.99 | 8.8% | 37.7% |
Total Expenses | 1519.11 | 1374.61 | 1021.31 | 10.5% | 48.7% |
Profit Before Tax | 308.87 | 373.69 | 359.68 | -17.3% | -14.1% |
Tax | 70.07 | 91.88 | 70.34 | -23.7% | -0.4% |
Profit After Tax | 238.80 | 281.81 | 289.34 | -15.3% | -17.5% |
Earnings Per Share | 2.40 | 2.90 | 3.00 | -17.2% | -20.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
## Company Overview
Max Healthcare Institute Ltd. operates in the healthcare sector, providing a range of medical and healthcare services. While specific details regarding the company's main products or services were not provided, it typically involves hospital and healthcare operations. The company is a significant player in the healthcare industry in India. Recent major developments, if any, are not available in the provided data.
## Revenue
In the third quarter of fiscal year 2025 (Q3FY25), Max Healthcare Institute Ltd. reported a total income of ₹1901.61 crores. This represents an increase of 8.8% from ₹1748.30 crores in the previous quarter (Q2FY25) and a substantial year-over-year growth of 37.7% from ₹1380.99 crores in Q3FY24. The company experienced a significant rise in revenue on both a quarterly and yearly basis.
## Profitability
For Q3FY25, the Profit Before Tax (PBT) stood at ₹308.87 crores, which marks a decline of 17.3% from ₹373.69 crores in Q2FY25 and a decrease of 14.1% from ₹359.68 crores in Q3FY24. After accounting for a tax expense of ₹70.07 crores, the Profit After Tax (PAT) came to ₹238.80 crores, down by 15.3% from ₹281.81 crores in the previous quarter and by 17.5% from ₹289.34 crores in the same quarter of the previous year. Earnings Per Share (EPS) also fell to ₹2.40, compared to ₹2.90 in Q2FY25 and ₹3.00 in Q3FY24, reflecting a decrease of 17.2% QoQ and 20.0% YoY.
## Operating Metrics
Total expenses for Q3FY25 were recorded at ₹1519.11 crores, indicating an increase of 10.5% from ₹1374.61 crores in the preceding quarter and a 48.7% surge compared to ₹1021.31 crores in Q3FY24. The company's expenses have risen significantly both on a quarterly and yearly basis. Key financial ratios such as the P/E ratio, debt-to-equity ratio, and current ratio are not calculable from the provided data. The data reveals trends in income and expense patterns but does not offer insights into other operational aspects such as asset utilization or cash flow specifics.
Open Demat Account
